161 related articles for article (PubMed ID: 38715682)
1. Association of the Reduced Function Met420del Polymorphism of SLC22A1 with Metformin-Induced Gastrointestinal Intolerance in Ethiopian Patients with Type 2 Diabetes Mellitus.
Degaga A; Sirgu S; Huri HZ; Sim MS; Loganadan NK; Kebede T; Tegene B; Engidawork E; Shibeshi W
Pharmgenomics Pers Med; 2024; 17():183-191. PubMed ID: 38715682
[TBL] [Abstract][Full Text] [Related]
2. Association of Met420del Variant of Metformin Transporter Gene SLC22A1 with Metformin Treatment Response in Ethiopian Patients with Type 2 Diabetes.
Degaga A; Sirgu S; Huri HZ; Sim MS; Kebede T; Tegene B; Loganadan NK; Engidawork E; Shibeshi W
Diabetes Metab Syndr Obes; 2023; 16():2523-2535. PubMed ID: 37641646
[TBL] [Abstract][Full Text] [Related]
3. Allele Frequency of
Ningrum VD; Istikharah R; Firmansyah R
Open Access Maced J Med Sci; 2019 Feb; 7(3):378-383. PubMed ID: 30834005
[TBL] [Abstract][Full Text] [Related]
4. Organic cation transporter 1 variants and gastrointestinal side effects of metformin in patients with Type 2 diabetes.
Dujic T; Causevic A; Bego T; Malenica M; Velija-Asimi Z; Pearson ER; Semiz S
Diabet Med; 2016 Apr; 33(4):511-4. PubMed ID: 26605869
[TBL] [Abstract][Full Text] [Related]
5. Variation in the Plasma Membrane Monoamine Transporter (PMAT) (Encoded by
Dawed AY; Zhou K; van Leeuwen N; Mahajan A; Robertson N; Koivula R; Elders PJM; Rauh SP; Jones AG; Holl RW; Stingl JC; Franks PW; McCarthy MI; 't Hart LM; Pearson ER;
Diabetes Care; 2019 Jun; 42(6):1027-1033. PubMed ID: 30885951
[TBL] [Abstract][Full Text] [Related]
6. Association between organic cation transporter genetic polymorphisms and metformin response and intolerance in T2DM individuals: a systematic review and meta-analysis.
Peng A; Gong C; Xu Y; Liang X; Chen X; Hong W; Yan J
Front Public Health; 2023; 11():1183879. PubMed ID: 37546319
[TBL] [Abstract][Full Text] [Related]
7. Influence of SLC22A1 rs622342 genetic polymorphism on metformin response in South Indian type 2 diabetes mellitus patients.
Umamaheswaran G; Praveen RG; Damodaran SE; Das AK; Adithan C
Clin Exp Med; 2015 Nov; 15(4):511-7. PubMed ID: 25492374
[TBL] [Abstract][Full Text] [Related]
8.
Liu Z; Jia X; Wu P; Wu B; Pan Y; Zhong S; Xiao L; Song Y; Hu J; Zhou K
Pharmacogenomics; 2023 Jul; 24(10):551-560. PubMed ID: 37458617
[No Abstract] [Full Text] [Related]
9. The influence of metformin transporter gene SLC22A1 and SLC47A1 variants on steady-state pharmacokinetics and glycemic response.
Ningrum VDA; Sadewa AH; Ikawati Z; Yuliwulandari R; Ikhsan MR; Fajriyah R
PLoS One; 2022; 17(7):e0271410. PubMed ID: 35905099
[TBL] [Abstract][Full Text] [Related]
10. Reduced-function SLC22A1 polymorphisms encoding organic cation transporter 1 and glycemic response to metformin: a GoDARTS study.
Zhou K; Donnelly LA; Kimber CH; Donnan PT; Doney AS; Leese G; Hattersley AT; McCarthy MI; Morris AD; Palmer CN; Pearson ER
Diabetes; 2009 Jun; 58(6):1434-9. PubMed ID: 19336679
[TBL] [Abstract][Full Text] [Related]
11. The influence of
Ebid AIM; Ehab M; Ismail A; Soror S; Mahmoud MA
J Drug Assess; 2019; 8(1):115-121. PubMed ID: 31231590
[No Abstract] [Full Text] [Related]
12. Altered Glycemic Control Associated With Polymorphisms in the SLC22A1 (OCT1) Gene in a Mexican Population With Type 2 Diabetes Mellitus Treated With Metformin: A Cohort Study.
Reséndiz-Abarca CA; Flores-Alfaro E; Suárez-Sánchez F; Cruz M; Valladares-Salgado A; Del Carmen Alarcón-Romero L; Vázquez-Moreno MA; Wacher-Rodarte NA; Gómez-Zamudio JH
J Clin Pharmacol; 2019 Oct; 59(10):1384-1390. PubMed ID: 31012983
[TBL] [Abstract][Full Text] [Related]
13. Genetic and Phenotypic Factors Affecting Glycemic Response to Metformin Therapy in Patients with Type 2 Diabetes Mellitus.
Nasykhova YA; Barbitoff YA; Tonyan ZN; Danilova MM; Nevzorov IA; Komandresova TM; Mikhailova AA; Vasilieva TV; Glavnova OB; Yarmolinskaya MI; Sluchanko EI; Glotov AS
Genes (Basel); 2022 Jul; 13(8):. PubMed ID: 35893047
[TBL] [Abstract][Full Text] [Related]
14.
Wu K; Li X; Xu Y; Zhang X; Guan Z; Zhang S; Li Y
Int J Endocrinol; 2020; 2020():2975898. PubMed ID: 32454819
[TBL] [Abstract][Full Text] [Related]
15. Effect of Serotonin Transporter 5-HTTLPR Polymorphism on Gastrointestinal Intolerance to Metformin: A GoDARTS Study.
Dujic T; Zhou K; Tavendale R; Palmer CN; Pearson ER
Diabetes Care; 2016 Nov; 39(11):1896-1901. PubMed ID: 27493135
[TBL] [Abstract][Full Text] [Related]
16. rs622342 in
Naja K; Salami A; El Shamieh S; Fakhoury R
J Pers Med; 2020 Jun; 10(2):. PubMed ID: 32575674
[TBL] [Abstract][Full Text] [Related]
17. Association of SLC22A1 rs622342 and ATM rs11212617 polymorphisms with metformin efficacy in patients with type 2 diabetes.
Chen P; Cao Y; Guo Y; Xu Q; Wang X; Zhang L; Liu Z; Chen D; Chen S; Chen S
Pharmacogenet Genomics; 2022 Feb; 32(2):67-71. PubMed ID: 34545025
[TBL] [Abstract][Full Text] [Related]
18. Microbiome differences related to metformin intolerance among Black individuals with diabetes, a pilot cross-sectional study.
Fayfman M; Gewirtz AT; Delaroque C; Blanco G; Gibanica S; Srinivasan S; Chassaing B
Metabol Open; 2023 Dec; 20():100256. PubMed ID: 38115865
[TBL] [Abstract][Full Text] [Related]
19. The Impacts of SLC22A1 rs594709 and SLC47A1 rs2289669 Polymorphisms on Metformin Therapeutic Efficacy in Chinese Type 2 Diabetes Patients.
Xiao D; Guo Y; Li X; Yin JY; Zheng W; Qiu XW; Xiao L; Liu RR; Wang SY; Gong WJ; Zhou HH; Liu ZQ
Int J Endocrinol; 2016; 2016():4350712. PubMed ID: 26977146
[TBL] [Abstract][Full Text] [Related]
20. The role of clinical response to metformin in patients newly diagnosed with type 2 diabetes: a monotherapy study.
Mahrooz A; Parsanasab H; Hashemi-Soteh MB; Kashi Z; Bahar A; Alizadeh A; Mozayeni M
Clin Exp Med; 2015 May; 15(2):159-65. PubMed ID: 24740684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
